Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice

In recent years oral mucosal injury has been increasingly recognized as an important toxicity associated with mammalian target of rapamycin (mTOR) inhibitors, including in patients with breast cancer who are receiving everolimus. This review addresses the state‐of‐the‐science regarding mTOR inhibito...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Peterson, Douglas E., O'Shaughnessy, Joyce A., Rugo, Hope S., Elad, Sharon, Schubert, Mark M., Viet, Chi T., Campbell‐Baird, Cynthia, Hronek, Jan, Seery, Virginia, Divers, Josephine, Glaspy, John, Schmidt, Brian L., Meiller, Timothy F.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4971919/
https://ncbi.nlm.nih.gov/pubmed/27334013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados